Founded on laboratory precision, software governance, and connected clinical operations.
Roche Diagnostics serves hospital laboratories, reference laboratories, point-of-care programs, and remote care teams that need validated results, interoperable data, and reliable service. The brand is represented here as a large global diagnostics organization focused on in-vitro diagnostics and patient monitoring workflows. Its operating model brings together analyzer engineering, reagent logistics, regulated software, clinical evidence, and implementation services so a customer can discuss test menu expansion and digital result delivery in the same planning cycle.
For procurement and laboratory leadership, the most important question is rarely whether a single analyzer can run a single assay. The harder questions are whether the platform can fit the LIS, maintain QC discipline, support operator competency, preserve lot traceability, respond to cybersecurity events, and keep service response aligned with patient care urgency. Roche Diagnostics positions those questions as part of the main system architecture, not as afterthoughts.
Company facts
- Primary focus
- In-vitro diagnostics, laboratory automation, point-of-care workflows, and connected remote care programs.
- Quality system
- ISO 13485:2016-aligned medical device quality management with DHF, DMR, DHR, CAPA, and PMS controls.
- Interoperability
- HL7 v2.5.1, FHIR observation workflows, LIS middleware, and secure result delivery planning.
- Clinical evidence
- Validation packs include precision, linearity, method comparison, QC performance, and intended-use review.
- Service model
- Remote telemetry, preventive maintenance, application specialist support, and biomedical escalation planning.
- Data governance
- Role-based access, audit logs, cybersecurity bulletins, SBOM review, and post-market software monitoring.
Certifications and governance approach
The governance approach emphasizes traceable design files, documented software lifecycle decisions, post-market surveillance, and clear language around regulatory status. For 510(k)-type products the site uses FDA cleared language, while European diagnostics claims are framed around CE IVDR where applicable. Internal planning documents are expected to distinguish marketing copy from validated intended use, and commercial teams are trained to avoid absolute medical promises.
- ISO 13485:2016 medical device QMS alignment for development, service, and supplier controls.
- CE IVDR 2017/746 documentation packages for applicable diagnostics workflows.
- IEC 62304-oriented lifecycle records for regulated software and connected diagnostics modules.
- Cybersecurity response process with SBOM review, CVE triage, and coordinated disclosure workflows.
Build a diagnostics roadmap with a team that understands analyzers, data, and service.
Talk with Roche Diagnostics about test menu consolidation, middleware upgrades, remote monitoring, and lifecycle service planning. A structured conversation can clarify validation evidence, cybersecurity responsibilities, and operational assumptions before a purchase order is drafted.
Contact